Publication:
Comparison of sonodynamic, photodynamic and sonophotodynamic therapy activity of fluorinated pyridine substituted silicon phthalocyanines on PC3 prostate cancer cell line

Loading...
Thumbnail Image

Date

Institution Authors

Item type:Person,

Unit of Researcher

Advisor

item.page.editor

Editor

Department

Journal Title

Journal ISSN

Volume Title

Publisher

ELSEVIER

DOI

10.1016/j.pdpdt.2023.103339
View PlumX Details

Research Projects

Organizational Units

Journal Issue

Abstract

Background: Sonophotodynamic therapy (SPDT), a combination of photodynamic therapy (PDT) and sonody-namic therapy (SDT), may offer theraputic advantage. The therapeutic effects of sonodynamic, photodynamic, and sonophotodynamic of 5-(trifluoromethyl)-2-thiopyridine substituted silicon phthalocyanine (gy3) and its quaternized derivative (gy3q) were examined in vitro on prostate cancer using PC3 cells.Methods: The SDT, PDT and SPDT efficiency was determined by using MTT test.Apoptosis mechanism was evaluated by HOPI staining.Results and Discussions: According to MTT results, the phthalocyanines decreased cell viability when compared with a control group. Also, apoptosis measurement data represents that the phthalocyanines would produce much better therapeutic outcomes compare to PDT and SDT by utilizing SPDT. Further studies should be per -formed to understand the effectiveness of SPDT.

Description

Journal or Series

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

ISSN

1572-1000

ISBN

Rights

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

0

Views

0

Downloads